We are live on ! Find out more
ALIM

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

30 hedge funds and large institutions have $146M invested in Alimera Sciences in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,328% more capital invested

Capital invested by funds: $10.3M → $146M (+$136M)

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

67% more funds holding

Funds holding: 1830 (+12)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
30
Holders Change
+12
Holders Change %
+66.67%
% of All Funds
0.48%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
12
Increased
5
Reduced
7
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CP
1
Caligan Partners
New York
$52.2M +$54.1M +16,356,377 +3,416%
VCIM
2
Velan Capital Investment Management
Georgia
$42.2M +$39.5M +11,948,879 +720%
SCM
3
Stonepine Capital Management
Oregon
$12.3M +$13.2M +3,983,686 New
BFM
4
Boothbay Fund Management
New York
$9.92M +$10.6M +3,198,708 New
ACM
5
Altium Capital Management
New York
$9.1M +$9.7M +2,934,108 New
ACM
6
AIGH Capital Management
Maryland
$7.35M +$7.84M +2,372,572 New
CC
7
Clearline Capital
New York
$7.24M +$7.72M +2,335,293 New
Morgan Stanley
8
Morgan Stanley
New York
$2.07M
WVP
9
Worth Venture Partners
New Jersey
$1.84M +$1.96M +593,709 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
10
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$775K
Vanguard Group
11
Vanguard Group
Pennsylvania
$455K +$17.5K +5,293 +4%
Renaissance Technologies
12
Renaissance Technologies
New York
$350K -$55.6K -16,822 -13%
Millennium Management
13
Millennium Management
New York
$278K +$167K +50,429 +128%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$164K -$21.5K -6,500 -11%
BCM
15
Bridgeway Capital Management
Texas
$62K -$60.5K -18,300 -48%
JFG
16
Jefferies Financial Group
New York
$40K +$42.6K +12,900 New
TRCT
17
Tower Research Capital (TRC)
New York
$37.2K +$29.5K +8,937 +292%
PCM
18
Perritt Capital Management
Illinois
$31K
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$23K -$39.2K -11,869 -61%
JP Morgan Chase
20
JP Morgan Chase
New York
$14.7K -$2.02K -612 -11%
Osaic Holdings
21
Osaic Holdings
Arizona
$12.6K -$24.8K -7,500 -65%
Bank of America
22
Bank of America
North Carolina
$7.75K +$8.26K +2,500 New
Citigroup
23
Citigroup
New York
$4.96K +$5.29K +1,600 New
BlackRock
24
BlackRock
New York
$1.66K
SR
25
Syntax Research
Florida
$248 +$264 +80 New

ALIM Hedge Fund Activity: Q3 2023 in Review

30 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2023, worth a combined $146M — up 1,328% from $10.3M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ALIM positions and 0 closed out — a net gain of 12 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Caligan Partners, adding an estimated $54.1M. The largest seller was Bridgeway Capital Management, cutting an estimated $60.5K.

  • 30 institutional investors held Alimera Sciences (ALIM) as of Q3 2023, up from 18 in Q2 2023.
  • Funds reported $146M of Alimera Sciences stock for Q3 2023, up 1,328% quarter-over-quarter.
  • 12 funds opened new Alimera Sciences positions in Q3 2023 and 0 closed out, a net change of +12 holders.
  • The largest Alimera Sciences buyer in Q3 2023 was Caligan Partners, an estimated $54.1M added.
  • The largest Alimera Sciences seller in Q3 2023 was Bridgeway Capital Management, an estimated $60.5K sold.

Based on aggregated 13F filings for Q3 2023.